ACTN4 and non-small cell lung carcinoma: Additionally, high levels of PHKA1‐AS1 could bind to the oncogene ACTN4, inhibiting its ubiquitination degradation and enhancing its protein stability, thus promoting NSCLC progression and metastasis.